Newborn Jaundice Treatment Market Report 2026

Newborn Jaundice Treatment Market Overview

• Newborn Jaundice Treatment market size has reached to $2.71 billion in 2025 • Expected to grow to $3.49 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Rising Birth Rates Driving Growth In The Market Due To Increasing Neonatal Care Demand • Market Trend: Non-Invasive Screening Technologies Advancing Newborn Jaundice Treatment Through Early Detection And Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Newborn Jaundice Treatment Market?

Newborn jaundice treatment refers to medical approaches used to reduce elevated bilirubin levels in infants that cause yellow discoloration of the skin and eyes. It includes therapeutic methods that help break down or remove excess bilirubin from the baby’s bloodstream to prevent complications. These treatments are designed to restore normal bilirubin levels and support healthy neonatal development safely. The main device types of newborn jaundice treatment include overhead phototherapy units, portable phototherapy units, and other device types. Overhead phototherapy units refer to fixed systems installed above the infant that deliver controlled light exposure to reduce bilirubin levels in a clinical setting. The various modalities involved are conventional phototherapy, light emitting diode phototherapy, and fiber optic phototherapy and the services include diagnostic and screening services, therapeutic and nursing services, and support and monitoring services. The various technologies involved are light emitting diode light sources, fluorescent, halogen, and fiberoptic systems, and they are used by several end users such as hospitals, neonatal intensive care units, pediatric clinics, and homecare settings.

What Is The Newborn Jaundice Treatment Market Growth Forecast?

The newborn jaundice treatment market size is expected to see strong growth in the next few years.It will grow to $3.49 billion by 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising adoption of LED-based phototherapy systems, increasing focus on early neonatal screening programs, growing demand for home-based newborn care solutions, advancements in non-invasive bilirubin monitoring technologies, expansion of neonatal intensive care infrastructure globally.Major trends in the forecast period include LED-based intensive phototherapy systems for rapid bilirubin reduction in neonates, fiber-optic blanket phototherapy enabling continuous treatment with minimal infant disruption, smart bilirubin monitoring systems integrated with real-time phototherapy adjustment, portable homecare phototherapy devices supporting early hospital discharge, dual-surface phototherapy units enhancing treatment efficiency in neonatal intensive care.

Global Newborn Jaundice Treatment Market Segmentation

1) By Device Type: Overhead Phototherapy Units, Portable Phototherapy Units, Other Device Types 2) By Modality: Conventional Phototherapy, Light Emitting Diode Phototherapy, Fiber Optic Phototherapy 3) By Service Type: Diagnostic And Screening Services, Therapeutic And Nursing Services, Support And Monitoring Services 4) By Technology: Light Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic 5) By End User: Hospitals, Neonatal Intensive Care Units, Pediatric Clinics, Homecare Settings Subsegments: 1) By Overhead Phototherapy Units: Light Emitting Diode Overhead Phototherapy Units, Fluorescent Lamp Overhead Phototherapy Units, Halogen Lamp Overhead Phototherapy Units, Double Surface Overhead Phototherapy Units 2) By Portable Phototherapy Units: Wearable Phototherapy Blanket Units, Fiber Optic Phototherapy Pad Units, Portable Light Emitting Diode Phototherapy Units, Compact Handheld Phototherapy Units 3) By Other Device Types: Phototherapy Bassinet Systems, Phototherapy Incubator Integrated Systems, Combination Phototherapy And Warming Units, Multisurface Phototherapy Systems

What Is The Driver Of The Newborn Jaundice Treatment Market?

The rising birth rates are expected to propel the growth of the newborn jaundice treatment industry going forward.Birth rates refer to the number of live births within a specific population over a given period, reflecting overall population growth and reproductive trends.The increase in birth rates is driven by improving maternal healthcare access, population growth, and supportive government policies in certain regions, leading to a higher number of newborns requiring postnatal care.Newborn jaundice treatment supports this trend by enabling early diagnosis and effective management of bilirubin levels in a growing neonatal population through phototherapy and related interventions, thereby reducing the risk of complications.For instance, in July 2025, according to the Office for National Statistics, a UK-based government department, there were 594,677 live births in England and Wales in 2024, an increase of 3,605 (0.6%) compared to 2023, marking the first rise since 2021.Therefore, rising birth rates are driving the growth of the newborn jaundice treatment industry.

Key Players In The Global Newborn Jaundice Treatment Market

Major companies operating in the newborn jaundice treatment market are Koninklijke Philips N. V., GE HealthCare Technologies, Drägerwerk AG & Co. KGaA, Heal Force Bio-Meditech Holdings Limited, Atom Medical, Ningbo David Medical Device, Fanem Ltd., MTTS Inc., Phoenix Medical Systems, Olidef Medical, Dixion Vertrieb Medizinischer Geräte GmbH, Anandic Medical Systems AG, Weyer GmbH, AVI Healthcare Pvt. Ltd., Nice Neotech, Natus Medical, Ibis Medical, Novos Medical Systems, GINEVRI Srl, Solarc Systems Inc., Cobams Srl, Kay & Company, Nareena Lifesciences Private Limited, Alfamedic, Delta

Global Newborn Jaundice Treatment Market Trends and Insights

Major companies operating in the newborn jaundice treatment market are focusing on advanced non-invasive screening solutions, such as smartphone-based bilirubin detection technologies, to enable early diagnosis and improve accessibility of care. Smartphone-based bilirubin detection utilizes mobile imaging and algorithm-based analysis of skin coloration to estimate bilirubin levels without the need for blood sampling or specialized equipment. For instance, in July 2024, Konica Minolta, a Japan-based technology company, collaborated with Picterus AS, a Norway-based digital health company, to enhance non-invasive jaundice screening solutions. The collaboration leverages smartphone-based imaging to enable early detection, improve accessibility in low-resource settings, and support timely intervention while maintaining screening accuracy. Additionally, the solution reduces dependence on hospital-based diagnostic tools and enables point-of-care screening in community and home settings. It also supports scalable neonatal screening programs by providing cost-effective, user-friendly technology for healthcare providers.

What Are Latest Mergers And Acquisitions In The Newborn Jaundice Treatment Market?

In February 2026, Natus Sensory, a US-based medical technology company, acquired TheraB Medical for an undisclosed amount. Through this acquisition, Natus Sensory expanded its neonatal care portfolio by integrating wearable phototherapy technology, strengthening innovation in bilirubin management solutions, and broadening treatment accessibility across hospital and alternative care settings. TheraB Medical is an Israel-based medical device company specializing in wearable phototherapy solutions for neonatal jaundice management.

Regional Insights

North America was the largest region in the newborn jaundice treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Newborn Jaundice Treatment Market?

The newborn jaundice treatment market consists of revenues earned by entities by providing services such as diagnostic testing services, phototherapy treatment services, neonatal monitoring services, bilirubin screening services, and neonatal nursing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The newborn jaundice treatment market also includes sales of phototherapy devices, bilirubin monitoring systems, fiber optic phototherapy blankets, and neonatal care equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Newborn Jaundice Treatment Industry?

The newborn jaundice treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the newborn jaundice treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Newborn Jaundice Treatment Market Report 2026?

The newborn jaundice treatment market research report is one of a series of new reports from The Business Research Company that provides newborn jaundice treatment market statistics, including newborn jaundice treatment industry global market size, regional shares, competitors with a newborn jaundice treatment market share, detailed newborn jaundice treatment market segments, market trends and opportunities, and any further data you may need to thrive in the newborn jaundice treatment industry. This newborn jaundice treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.